Recombinant Human IL1R1 Protein，His

IL1R1, or Interleukin 1 Receptor Type 1, is a crucial component of the interleukin-1 signaling pathway, which plays a significant role in mediating inflammatory responses. As a receptor for interleukin-1 (IL-1), a pro-inflammatory cytokine, IL1R1 is involved in various biological processes, including cell proliferation, differentiation, and apoptosis. Dysregulation of IL1R1 signaling has been implicated in a range of inflammatory diseases, autoimmune disorders, and even cancer. The recombinant expression of IL1R1 protein is essential for advancing our understanding of its structure-function relationships and facilitating the development of therapeutic agents targeting IL-1 mediated pathways. Researchers have been focusing on producing recombinant IL1R1 to study its interaction with ligands and downstream signaling mechanisms, as well as to investigate its potential as a therapeutic target. The availability of purified IL1R1 protein allows for in-depth biochemical assays and structural studies, which can elucidate how mutations or alterations in this receptor may influence disease progression. Moreover, the recombinant protein can serve as a valuable tool in drug discovery processes aimed at developing IL-1 inhibitors for treating various inflammatory conditions. Understanding the role and functioning of IL1R1 through its recombinant protein form holds promise for identifying novel therapeutic strategies and enhancing our overall grasp of inflammatory diseases.